In restructuring roughly 40 percent of the company’s leadership, Ms. Walmsley hired people outside the company from various corporations, including Google and Novartis AG, and promoted select individuals from within, the London-based company said in an email to Bloomberg.
Ms. Walmsley said in July Glaxo must focus on developing treatments for respiratory conditions, HIV, and infectious and autoimmune disorders, as well as end or divest roughly 30 drug-development programs to spur long-term growth, according to the report.
More articles on supply chain:
6 drug, devicemakers in the headlines
Kick-start your supply chain in 2018: 3 New Year’s Resolutions
Drug charity stops financial assistance services following HHS scrutiny
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
